Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
47
CSU.TO Quote, Financials, Valuation and Earnings
Last price:
$4,976.98
Seasonality move
:
2.87%
Day range:
$4,900.00 - $4,976.98
52-week range:
$3,920.00 - $5,300.00
Dividend yield:
0.11%
P/E ratio:
102.67x
P/S ratio:
7.32x
P/B ratio:
24.20x
Volume:
25.6K
Avg. volume:
26.6K
1-year change:
18.48%
Market cap:
$105.5B
Revenue:
$13.8B
EPS (TTM):
$48.48
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $5.3B | $6.4B | $8.6B | $11.3B | $13.8B | |
| Revenue Growth (YoY) | 14.89% | 20.32% | 34.42% | 31.89% | 21.35% | |
| Cost of Revenues | $572.2M | $666.6M | $987.3M | $1.3B | $1.5B | |
| Gross Profit | $4.7B | $5.7B | $7.6B | $10B | $12.2B | |
| Gross Profit Margin | 89.24% | 89.58% | 88.52% | 88.48% | 88.78% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $3.1B | $3.8B | $5.2B | $6.9B | $8.3B | |
| Other Inc / (Exp) | -$120.6M | -$622.8M | -$281.9M | -$1.2B | -$567.6M | |
| Operating Expenses | $3.8B | $4.6B | $6.3B | $8.3B | $10B | |
| Operating Income | $987.7M | $1.2B | $1.3B | $1.8B | $2.2B | |
| Net Interest Expenses | $57.6M | $78.9M | $122.1M | $221.4M | $300.9M | |
| EBT. Incl. Unusual Items | $808.1M | $468.7M | $941.8M | $357.7M | $1.4B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $223.8M | $258.1M | $227.3M | $275.4M | $333.7M | |
| Net Income to Company | $584.3M | $211.8M | $715.8M | $83.7M | $1B | |
| Minority Interest in Earnings | -- | $177.9M | -$49.4M | $679M | -$50.6M | |
| Net Income to Common Excl Extra Items | $584.3M | $388.5M | $665.1M | $762.6M | $999.8M | |
| Basic EPS (Cont. Ops) | $27.59 | $18.36 | $31.41 | $36.00 | $47.16 | |
| Diluted EPS (Cont. Ops) | $27.59 | $18.36 | $31.41 | $36.00 | $47.16 | |
| Weighted Average Basic Share | $21.2M | $21.2M | $21.2M | $21.2M | $21.2M | |
| Weighted Average Diluted Share | $21.2M | $21.2M | $21.2M | $21.2M | $21.2M | |
| EBITDA | $1.5B | $1.3B | $2.1B | $2B | $3.4B | |
| EBIT | $863M | $535.1M | $1.1B | $577.7M | $1.7B | |
| Revenue (Reported) | $5.3B | $6.4B | $8.6B | $11.3B | $13.8B | |
| Operating Income (Reported) | $987.7M | $1.2B | $1.3B | $1.8B | $2.2B | |
| Operating Income (Adjusted) | $863M | $535.1M | $1.1B | $577.7M | $1.7B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.5B | $1.8B | $2.6B | $3.2B | $3.8B | |
| Revenue Growth (YoY) | 16.42% | 21.75% | 43.2% | 22.3% | 19.76% | |
| Cost of Revenues | $149.3M | $188.7M | $297.6M | $337M | $421.1M | |
| Gross Profit | $1.3B | $1.6B | $2.3B | $2.8B | $3.4B | |
| Gross Profit Margin | 89.97% | 89.59% | 88.53% | 89.38% | 88.92% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $891M | $1.1B | $1.6B | $2B | $2.3B | |
| Other Inc / (Exp) | -$402.5M | -$79.8M | -$368M | -$245.3M | -$257.8M | |
| Operating Expenses | $1.1B | $1.3B | $1.9B | $2.3B | $2.8B | |
| Operating Income | $262M | $291.2M | $351.7M | $486.6M | $621.7M | |
| Net Interest Expenses | $16.5M | $20.3M | $44.6M | $72.8M | $40.1M | |
| EBT. Incl. Unusual Items | -$159.5M | $191.2M | -$58.2M | $168.5M | $325.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $62M | $50.7M | $54.1M | $70.1M | $124.6M | |
| Net Income to Company | -$221.5M | $140.6M | -$112.3M | $99.8M | $200.5M | |
| Minority Interest in Earnings | $210.1M | -$16.5M | $239.5M | $41.8M | -$34.4M | |
| Net Income to Common Excl Extra Items | -$11.4M | $124.1M | $127.2M | $141.5M | $164.7M | |
| Basic EPS (Cont. Ops) | -$0.52 | $5.86 | $6.01 | $6.67 | $7.79 | |
| Diluted EPS (Cont. Ops) | -$0.52 | $5.86 | $6.01 | $6.67 | $7.79 | |
| Weighted Average Basic Share | $21.2M | $21.2M | $21.2M | $21.2M | $21.2M | |
| Weighted Average Diluted Share | $21.2M | $21.2M | $21.2M | $21.2M | $21.2M | |
| EBITDA | $41.8M | $434.3M | $296.3M | $632.2M | $870.9M | |
| EBIT | -$144.3M | $208.9M | -$17.6M | $246.7M | $415.4M | |
| Revenue (Reported) | $1.5B | $1.8B | $2.6B | $3.2B | $3.8B | |
| Operating Income (Reported) | $262M | $291.2M | $351.7M | $486.6M | $621.7M | |
| Operating Income (Adjusted) | -$144.3M | $208.9M | -$17.6M | $246.7M | $415.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $5.5B | $6.7B | $9.4B | $11.9B | $14.4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $585.3M | $705.9M | $1.1B | $1.3B | $1.6B | |
| Gross Profit | $4.9B | $6B | $8.3B | $10.6B | $12.8B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $3.2B | $4B | $5.7B | $7.2B | $8.6B | |
| Other Inc / (Exp) | -$493.1M | -$300M | -$566.5M | -$1.1B | -$583.4M | |
| Operating Expenses | $3.9B | $4.8B | $6.9B | $8.7B | $10.4B | |
| Operating Income | $1B | $1.2B | $1.4B | $1.9B | $2.4B | |
| Net Interest Expenses | $64.4M | $80.3M | $148.9M | $249.5M | $265.7M | |
| EBT. Incl. Unusual Items | $492M | $816.9M | $695.1M | $580.9M | $1.5B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $241.9M | $246.8M | $230.9M | $291.1M | $388M | |
| Net Income to Company | $251.5M | $573.8M | $462.9M | $295.7M | $1.1B | |
| Minority Interest in Earnings | $210.1M | -$47M | $206.6M | $484.1M | -$128.1M | |
| Net Income to Common Excl Extra Items | $458.9M | $523.1M | $670.7M | $776.5M | $1B | |
| Basic EPS (Cont. Ops) | $21.69 | $24.70 | $31.68 | $36.64 | $48.48 | |
| Diluted EPS (Cont. Ops) | $21.69 | $24.70 | $31.68 | $36.64 | $48.48 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $1.3B | $1.7B | $2B | $2.3B | $3.6B | |
| EBIT | $550M | $884.6M | $831.7M | $838.6M | $1.9B | |
| Revenue (Reported) | $5.5B | $6.7B | $9.4B | $11.9B | $14.4B | |
| Operating Income (Reported) | $1B | $1.2B | $1.4B | $1.9B | $2.4B | |
| Operating Income (Adjusted) | $550M | $884.6M | $831.7M | $838.6M | $1.9B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.5B | $1.8B | $2.6B | $3.2B | $3.8B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $149.3M | $188.7M | $297.6M | $337M | $421.1M | |
| Gross Profit | $1.3B | $1.6B | $2.3B | $2.8B | $3.4B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $891M | $1.1B | $1.6B | $2B | $2.3B | |
| Other Inc / (Exp) | -$402.5M | -$79.8M | -$368M | -$245.3M | -$257.8M | |
| Operating Expenses | $1.1B | $1.3B | $1.9B | $2.3B | $2.8B | |
| Operating Income | $262M | $291.2M | $351.7M | $486.6M | $621.7M | |
| Net Interest Expenses | $16.5M | $20.3M | $44.6M | $72.8M | $40.1M | |
| EBT. Incl. Unusual Items | -$159.5M | $191.2M | -$58.2M | $168.5M | $325.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $62M | $50.7M | $54.1M | $70.1M | $124.6M | |
| Net Income to Company | -$221.5M | $140.6M | -$112.3M | $99.8M | $200.5M | |
| Minority Interest in Earnings | $210.1M | -$16.5M | $239.5M | $41.8M | -$34.4M | |
| Net Income to Common Excl Extra Items | -$11.4M | $124.1M | $127.2M | $141.5M | $164.7M | |
| Basic EPS (Cont. Ops) | -$0.52 | $5.86 | $6.01 | $6.67 | $7.79 | |
| Diluted EPS (Cont. Ops) | -$0.52 | $5.86 | $6.01 | $6.67 | $7.79 | |
| Weighted Average Basic Share | $21.2M | $21.2M | $21.2M | $21.2M | $21.2M | |
| Weighted Average Diluted Share | $21.2M | $21.2M | $21.2M | $21.2M | $21.2M | |
| EBITDA | $41.8M | $434.3M | $296.3M | $632.2M | $870.9M | |
| EBIT | -$144.3M | $208.9M | -$17.6M | $246.7M | $415.4M | |
| Revenue (Reported) | $1.5B | $1.8B | $2.6B | $3.2B | $3.8B | |
| Operating Income (Reported) | $262M | $291.2M | $351.7M | $486.6M | $621.7M | |
| Operating Income (Adjusted) | -$144.3M | $208.9M | -$17.6M | $246.7M | $415.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $966.5M | $972.4M | $1.1B | $1.7B | $2.8B | |
| Short Term Investments | $11.5M | $49.7M | $156M | $18.6M | $20.1M | |
| Accounts Receivable, Net | $615.9M | $764.7M | $1.2B | $1.5B | $1.9B | |
| Inventory | $34.4M | $44.6M | $65.1M | $67.6M | $80.4M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $147.9M | $198.8M | $301.2M | $368.7M | $457.8M | |
| Total Current Assets | $2B | $2.3B | $3.3B | $4.4B | $6.2B | |
| Property Plant And Equipment | $429.7M | $432M | $558.9M | $600.7M | $790.7M | |
| Long-Term Investments | $2.6M | $2.5M | $4.1M | $13.3M | $20.1M | |
| Goodwill | $549.6M | $777.4M | $1.1B | $1.7B | $2.1B | |
| Other Intangibles | $2.4B | $3.6B | $5.3B | $7.2B | $8.6B | |
| Other Long-Term Assets | $3.8M | -$1.3M | -- | $255.9M | $292.7M | |
| Total Assets | $5.6B | $7.3B | $10.7B | $14.4B | $18.5B | |
| Accounts Payable | $849.2M | $1.1B | $1.5B | $1.9B | $2.3B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $179.8M | $258.7M | $1.1B | $1.4B | $892.6M | |
| Current Portion Of Capital Lease Obligations | $94.4M | $100.7M | $130.2M | $148.5M | $165M | |
| Other Current Liabilities | $1.3M | $7.6M | -- | $1.1B | -- | |
| Total Current Liabilities | $2.6B | $3.1B | $5.1B | $7.3B | $6.7B | |
| Long-Term Debt | $790.5M | $1.2B | $1.6B | $3B | $5.1B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $4.2B | $5.4B | $8.1B | $11.8B | $13.7B | |
| Common Stock | $126.2M | $126.2M | $134.3M | $131.3M | $142.1M | |
| Other Common Equity Adj | -$39.5M | -$84.1M | -$203.5M | -$131.3M | -$321.4M | |
| Common Equity | $1.3B | $1.4B | $2.3B | $2.5B | $4B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | $586.2M | $299.8M | $112.7M | $707.4M | |
| Total Equity | $1.3B | $1.9B | $2.6B | $2.6B | $4.7B | |
| Total Liabilities and Equity | $5.6B | $7.3B | $10.7B | $14.4B | $18.5B | |
| Cash and Short Terms | $978M | $1B | $1.3B | $1.7B | $2.9B | |
| Total Debt | $970.3M | $1.4B | $2.7B | $4.4B | $6B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.2B | $1.2B | $1.4B | $2.8B | $3.5B | |
| Short Term Investments | $12.6M | $162.3M | -- | -- | $15.7M | |
| Accounts Receivable, Net | $653.8M | $823.8M | $1.4B | $1.6B | $2B | |
| Inventory | $34.1M | $51.2M | $67.6M | $79.9M | $83M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $175.4M | $230.9M | $371.9M | $769M | $490.8M | |
| Total Current Assets | $2.4B | $2.9B | $3.8B | $5.8B | $7.1B | |
| Property Plant And Equipment | $451.8M | $469.3M | $559.8M | $613.3M | $812.8M | |
| Long-Term Investments | $3.8M | $2.5M | $4.1M | $9.5M | $526.6M | |
| Goodwill | $607.1M | $811.3M | $1.2B | $1.7B | $2.1B | |
| Other Intangibles | $2.9B | $3.7B | $6.1B | $7.4B | $8.6B | |
| Other Long-Term Assets | -- | -- | $1.4M | $285.7M | $276.2M | |
| Total Assets | $6.5B | $8.1B | $12B | $16.1B | $19.9B | |
| Accounts Payable | $803.9M | $963.6M | $1.5B | $1.8B | $2.1B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $196.9M | $332M | $918.1M | $844.8M | $738.3M | |
| Current Portion Of Capital Lease Obligations | $97.2M | $106.1M | $132.5M | $153M | $170.3M | |
| Other Current Liabilities | $492.2M | $1.2M | $551.7M | -- | $1.4M | |
| Total Current Liabilities | $3.5B | $3.7B | $6.2B | $6.3B | $7.5B | |
| Long-Term Debt | $1B | $1.3B | $1.9B | $4.5B | $5.1B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $5.4B | $6.1B | $9.5B | $12.4B | $14.7B | |
| Common Stock | $124.9M | $123.6M | $133.9M | $134M | $141.7M | |
| Other Common Equity Adj | -$84.6M | -$77.4M | -$173.1M | -$196.3M | -$90.1M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $18.9M | $238.4M | $566.6M | $594.4M | $851.4M | |
| Total Equity | $1.1B | $2B | $2.5B | $3.7B | $5.2B | |
| Total Liabilities and Equity | $6.5B | $8.1B | $12B | $16.1B | $19.9B | |
| Cash and Short Terms | $1.2B | $1.4B | $1.4B | $2.8B | $3.6B | |
| Total Debt | $1.2B | $1.6B | $2.8B | $5.3B | $6.2B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $584.3M | $211.8M | $715.8M | $83.7M | $1B | |
| Depreciation & Amoritzation | $680.8M | $800.7M | $1.1B | $1.4B | $1.7B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $60.3M | -$43.9M | -$139M | -$153.9M | -$91.6M | |
| Change in Inventories | $10.7M | $1.3M | -$11.7M | $5.4M | $8.2M | |
| Cash From Operations | $1.6B | $1.6B | $1.7B | $2.4B | $3B | |
| Capital Expenditures | $33.5M | $36.3M | $53.3M | $56.7M | $91.6M | |
| Cash Acquisitions | -$650M | -$1.5B | -$2B | -$2.3B | -$2.1B | |
| Cash From Investing | -$686.1M | -$1.6B | -$2.2B | -$2.2B | -$2.1B | |
| Dividends Paid (Ex Special Dividend) | -$113.9M | -$134.1M | -$149.4M | -$114.7M | -$203.8M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $64.3M | $220.5M | $1B | $885.5M | $1.9B | |
| Long-Term Debt Repaid | -$225.1M | -$111.5M | -$254.6M | -$527.8M | -$365.2M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$2.7M | -$2.5M | -$13M | -$4M | -$210.6M | |
| Cash From Financing | -$331M | -$51.4M | $627.4M | $426.5M | $155.9M | |
| Beginning Cash (CF) | $423.5M | $949.8M | $991.2M | $1.1B | $1.8B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $572.2M | $26.3M | $113M | $615.5M | $1B | |
| Ending Cash (CF) | $1B | $956.1M | $1.1B | $1.7B | $2.7B | |
| Levered Free Cash Flow | $1.6B | $1.6B | $1.6B | $2.3B | $2.9B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$221.5M | $140.6M | -$112.3M | $99.8M | $200.5M | |
| Depreciation & Amoritzation | $186M | $225.4M | $313.9M | $385.5M | $455.5M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$35.4M | -$73.4M | -$159.6M | -$114.6M | -$87.4M | |
| Change in Inventories | -- | -$3.8M | -$1.4M | -$6.7M | -- | |
| Cash From Operations | $626.5M | $630.6M | $855M | $993.5M | $1.2B | |
| Capital Expenditures | $5.1M | $10.1M | $13.5M | $13.5M | $21.5M | |
| Cash Acquisitions | -$399.9M | -$264.6M | -$648M | -$355.9M | -$141.8M | |
| Cash From Investing | -$403.7M | -$391.3M | -$538.4M | -$373.4M | -$388.2M | |
| Dividends Paid (Ex Special Dividend) | -$54.4M | -$64.6M | -$28.4M | -$114.6M | -$30.1M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $100M | $105.1M | $243.5M | $1.7B | $83.1M | |
| Long-Term Debt Repaid | -$26.6M | -$36.7M | -$150.2M | -$63.4M | -$87.4M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$5.1M | -$1.3M | -- | -$163.1M | -$1.4M | |
| Cash From Financing | $7.6M | $59.5M | -$58.2M | $473.2M | -$130.4M | |
| Beginning Cash (CF) | $959.3M | $966.2M | $1.1B | $1.7B | $2.8B | |
| Foreign Exchange Rate Adjustment | -$11.4M | -$2.5M | $9.5M | -$22.9M | $47.3M | |
| Additions / Reductions | $231.6M | $297.6M | $259.8M | $1.1B | $664.7M | |
| Ending Cash (CF) | $1.2B | $1.3B | $1.4B | $2.8B | $3.5B | |
| Levered Free Cash Flow | $621.4M | $620.5M | $841.5M | $980M | $1.2B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $251.5M | $573.8M | $462.9M | $295.7M | $1.1B | |
| Depreciation & Amoritzation | $707.2M | $840.1M | $1.2B | $1.4B | $1.7B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $55.7M | -$81.9M | -$225.2M | -$108.8M | -$64.4M | |
| Change in Inventories | $12.1M | -$2.5M | -$9.2M | $11.8K | $14.9M | |
| Cash From Operations | $1.7B | $1.6B | $1.9B | $2.5B | $3.2B | |
| Capital Expenditures | $29.2M | $41.4M | $56.7M | $56.6M | $99.6M | |
| Cash Acquisitions | -$882.2M | -$1.3B | -$2.4B | -$2B | -$1.9B | |
| Cash From Investing | -$911.4M | -$1.5B | -$2.3B | -$2B | -$2.2B | |
| Dividends Paid (Ex Special Dividend) | -$140.2M | -$144.2M | -$113.2M | -$200.9M | -$119.3M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $164.3M | $225.7M | $1.2B | $2.3B | $319.2M | |
| Long-Term Debt Repaid | -$231.6M | -$121.7M | -$368.1M | -$441M | -$389.2M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$6.4M | $1.3M | -- | -$167.2M | -$49M | |
| Cash From Financing | -$99.4M | $544.1K | $509.7M | $957.9M | -$447.6M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $722M | $92.3M | $75.2M | $1.4B | $589M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $1.7B | $1.6B | $1.9B | $2.5B | $3.1B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$221.5M | $140.6M | -$112.3M | $99.8M | $200.5M | |
| Depreciation & Amoritzation | $186M | $225.4M | $313.9M | $385.5M | $455.5M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$35.4M | -$73.4M | -$159.6M | -$114.6M | -$87.4M | |
| Change in Inventories | -- | -$3.8M | -$1.4M | -$6.7M | -- | |
| Cash From Operations | $626.5M | $630.6M | $855M | $993.5M | $1.2B | |
| Capital Expenditures | $5.1M | $10.1M | $13.5M | $13.5M | $21.5M | |
| Cash Acquisitions | -$399.9M | -$264.6M | -$648M | -$355.9M | -$141.8M | |
| Cash From Investing | -$403.7M | -$391.3M | -$538.4M | -$373.4M | -$388.2M | |
| Dividends Paid (Ex Special Dividend) | -$54.4M | -$64.6M | -$28.4M | -$114.6M | -$30.1M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $100M | $105.1M | $243.5M | $1.7B | $83.1M | |
| Long-Term Debt Repaid | -$26.6M | -$36.7M | -$150.2M | -$63.4M | -$87.4M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$5.1M | -$1.3M | -- | -$163.1M | -$1.4M | |
| Cash From Financing | $7.6M | $59.5M | -$58.2M | $473.2M | -$130.4M | |
| Beginning Cash (CF) | $959.3M | $966.2M | $1.1B | $1.7B | $2.8B | |
| Foreign Exchange Rate Adjustment | -$11.4M | -$2.5M | $9.5M | -$22.9M | $47.3M | |
| Additions / Reductions | $231.6M | $297.6M | $259.8M | $1.1B | $664.7M | |
| Ending Cash (CF) | $1.2B | $1.3B | $1.4B | $2.8B | $3.5B | |
| Levered Free Cash Flow | $621.4M | $620.5M | $841.5M | $980M | $1.2B | |
Get CSU.TO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CSU.TO
Sector
P/E ratio
102.67x
23.84x
PEG ratio
3.18x
0.00x
P/B ratio
24.20x
2.31x
Price / LTM sales
7.32x
1.64x
Growth Metrics
CSU.TO
Sector
Revenue growth
19.76%
3.84%
Earnings growth
16.78%
10.8%
Revenue (5-year growth)
24.36%
6.27%
Earnings forecast
$28.91
$0.12
Profitability
CSU.TO
Sector
Profitability FY 2024
$12.2B
$77.3M
Return on invested capital
10.17%
0.05%
Return on assets
5.83%
-0.48%
Return on equity
23.49%
0.73%
Earnings Date
Last Earnings Date
May
12
Next Earnings Date
Aug
8
Estimated Next Earnings Date
Aug
11
Balance Sheet
CSU.TO
Sector
Total cash
$3.6B
$48.7M
Short term investments
$20.1M
$19.4M
Total assets
$18.5B
$223.8M
Long term debt
$6.2B
$6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 4.23% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 1.05% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.1% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
